A study in The Lancet Haematology suggests this combination could become first-line for elderly or unhealthy patients with newly diagnosed AML.
A novel cancer vaccine targeting HER2-positive malignancies has progressed quickly from mouse trials into early-phase human trials, with promising results.
Dianne Shumay, PhD, director of psycho-oncology at UCSF, weighs in on how we can use psychological interventions to improve stress levels in cancer patients.
Plasma fibrinogen tests should be encouraged routinely in clinical practice to clarify its predictive benefit, according to a study.
A study shows undergoing treatment for DLBCL at a clinic with more experience was linked with important clinical outcomes.
The FDA authorized the first next-generation sequencing test to detect minimal residual disease in blood cancers.
A study shows gene variants of uncertain significance are frequently reclassified, necessitating amended test result reports.
Minimal residual disease negativity measured by next-generation sequencing was a valuable prognostic biomarker for multiple myeloma.
Different cytotoxic chemotherapy regimens are associated with varying rates of hospitalization following their use in older women with stage IV breast cancer.
The percentage of patients with pediatric melanoma is 6-fold to the 28-fold higher when compared with the general population of patients with melanoma.
A study shows stress may affect certain cellular, cytokine, and chemokine markers in the body of patients with CLL.
A study in Cancer found a lower risk of prostate cancer–specific death and improved overall survival when patients were treated with this combination.
A study shows treatment with ibrutinib is superior to chemoimmunotherapy for patients with chronic treatment-naive CLL.
Do you know about the quality of life obstacles for multiple myeloma patients? Take our latest quiz to test your knowledge.
A study shows T1a RCC patients have improved overall survival when receiving partial nephrectomy compared with radical nephrectomy.